A first-in-class multimodal organomercury compound demonstrates preferential blast reduction with improved hematopoietic and immune health in ALL
Sougata Mondal, Olina Ghosh, Basab Bagchi, Pratima Jana, Bidisha Maiti, Kalyan Kusum Mukherjee, Supratim Ghosh
This study evaluates -Mercurin, a new organomercury compound, showing better blast reduction and improved hematopoietic and immune health in a rat ALL model compared to cytarabine.
bioRxiv · Aug 21, 2026 · PreprintCancer Biology